Carlos A Acosta-Olivo

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Tranexamic acid tablets · Hematology / Hemostasis
Tranexamic acid inhibits fibrinolysis by blocking plasminogen activation, thereby reducing blood clot breakdown and promoting hemostasis.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Carlos A Acosta-Olivo portfolio CI brief
Carlos A Acosta-Olivo pipeline updates RSS

Frequently asked questions about Carlos A Acosta-Olivo

What is Carlos A Acosta-Olivo's pipeline?

Carlos A Acosta-Olivo has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Tranexamic acid tablets.

Sector hub: All tracked pharma companies